Uganda Housing Modification Study (UHMS)

Impact of Housing Modifications Combined With Piperonyl Butoxide (PBO) Long-lasting Insecticidal Nets (LLINs) on the Malaria Burden in Uganda: a Cluster-randomised Trial

To explore housing modification as a malaria control intervention, and to assess the degree to which it may offer protection in moderate to high malaria endemicity settings, we propose a two-phase study evaluating epidemiological and entomological effectiveness, cost-effectiveness, feasibility, and acceptability of housing modification in Uganda. The first phase will be a pilot implementation assessing the feasibility of candidate housing modification interventions, followed by a cluster randomised control trial of the most effective, scalable, and cost-effective interventions.

Study Overview

Detailed Description

The study will be conducted in two phases, beginning with a pilot (Phase I). The aim of the pilot will be to develop and test four types of housing modifications in both modern houses (those with brick or stone walls) and traditionally constructed houses (those with mud walls). The housing modifications will include: (1) full house screening (eaves and windows), (2) partial house screening (eaves or ceiling), (3) eave tubes, and (4) eave ribbons. Community input will be sought during the development of the housing prototypes.

In the pilot, all 4 interventions will be implemented in both modern and traditional houses, plus a control arm in each group. All households will have access to PBO LLINs. Community input will be sought during the development of the housing prototypes. The pilot will include 10 arms in total, each consisting of 20 households, equal to 200 households (160 in the intervention and 40 in the control arm) in total. The feasibility and effectiveness of the interventions will be assessed through a qualitative study (FGDs and interviews), evaluation of the costs and implementation of the interventions, and entomology surveys (using CDC light traps). One to two housing interventions will be selected for Phase II following the review and discussion of the pilot results with the trial steering committee.

Phase II will include a cluster-randomised trial. A cluster will be defined as a village (or segment of a village consisting of ~100 households). In the cluster-randomised trial, up to 2 interventions vs 1 control arm will be assessed in 20 clusters per arm (60 clusters total). The clusters will be non-contiguous, with a buffer zone of 300-500m. All households in the selected clusters will have PBO LLINs; households in intervention clusters will also receive the specified housing modifications. The impact of the interventions will be assessed through a cohort study, cross-sectional community surveys, entomology surveillance, a qualitative study, and an economic evaluation. The primary outcome of the trial will be clinical malaria incidence in children aged < 60 months as measured in the cohort study.

Study Type

Interventional

Enrollment (Actual)

2422

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central Region
      • Kampala, Central Region, Uganda
        • Infectious Diseases Research Collaboration

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 14 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Phase I

Inclusion criteria

  • At least one adult aged 18 years or older present
  • Agreement of the adult resident to provide informed consent for the pilot study

Phase II

Cohort Study

Inclusion Criteria:

  • Household considered their primary residence
  • Child aged less than 59 months
  • Agreement to come to the study clinic for any febrile illness
  • Agreement to avoid antimalarial medications outside the study
  • Provision of written informed consent (for parent or guardian in case of children)

Cross-sectional Community Survey - Household Survey

Inclusion Criteria:

  • At least one household resident between 6 months and 14 years of age present (with an adult caregiver willing to provide informed consent for the clinical survey)
  • At least one adult aged 18 years or older present
  • Adult is a usual resident who slept in the sampled household on the night before the survey
  • Agreement of the adult resident to provide informed consent for the household survey

Exclusion Criteria:

  • Dwelling destroyed or not found
  • Household vacant
  • No adult resident home on more than 3 occasions

Cross-sectional Community Survey - Clinical Survey

Inclusion Criteria:

  • Child aged 6 months to 14 years
  • Usual resident who was present in the sampled household on the night before the survey
  • Agreement of parent/guardian to provide informed consent
  • Agreement of child aged 8 years or older to provide assent

Exclusion Criterion:

  • Child not home on day of survey

Recruitment of Field Workers for entomology activities (human landing catches).

Inclusion Criteria:

  • Willingness to take chemoprophylaxis for malaria
  • Willingness to abstain from alcohol during working hours
  • No significant past medical history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Eave Tubes - Traditional House
Installation of eave tubes in traditional homes.
The eave tubes are PVC tubes with a diameter of 15 cm installed in the outer wall of occupied rooms (e.g. bedrooms and living rooms but not storage rooms) at 1.5-2 m intervals, fitted with electrostatic mesh inserts coated with insecticides. No additional screening will be done. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Experimental: Eave Tubes - Modern House
Installation of eave tubes in modern homes.
The eave tubes are PVC tubes with a diameter of 15 cm installed in the outer wall of occupied rooms (e.g. bedrooms and living rooms but not storage rooms) at 1.5-2 m intervals, fitted with electrostatic mesh inserts coated with insecticides. No additional screening will be done. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Experimental: Eave Ribbons - Traditional House
Installation of eave ribbons in traditional homes.

Eave ribbons are 15 cm-wide triple-layered hessian fabrics (burlap-line fabric woven from sisal fibres, procured locally), in lengths starting 1 m that can be attached to houses using nails, adhesives or Velcro, without completely closing eave-spaces. The eave ribbons will be treated by study staff with a commonly used spatial repellent, transfluthrin. Eave ribbons will be retreated by study staff after 6 months (only in Phase II, if selected for inclusion in the cluster-randomised trial).

All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.

Experimental: Eave Ribbons - Modern House
Installation of eave ribbons in modern homes.

Eave ribbons are 15 cm-wide triple-layered hessian fabrics (burlap-line fabric woven from sisal fibres, procured locally), in lengths starting 1 m that can be attached to houses using nails, adhesives or Velcro, without completely closing eave-spaces. The eave ribbons will be treated by study staff with a commonly used spatial repellent, transfluthrin. Eave ribbons will be retreated by study staff after 6 months (only in Phase II, if selected for inclusion in the cluster-randomised trial).

All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.

Experimental: Full House Screening - Traditional House
Installation of full house screening, includes screening eaves and windows, in traditional homes.
Full house screening includes screening eaves/ceilings, ventilation openings, and windows. Eaves/ceiling, air vents, and windows of eligible houses will be screened with wire mesh or other locally available screening materials. or ceilings, if eaves are closed" and ventilation openings. We are also filling in any gaps in the walls. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Experimental: Full House Screening - Modern House
Installation of full house screening, includes screening eaves and windows, in modern homes.
Full house screening includes screening eaves/ceilings, ventilation openings, and windows. Eaves/ceiling, air vents, and windows of eligible houses will be screened with wire mesh or other locally available screening materials. or ceilings, if eaves are closed" and ventilation openings. We are also filling in any gaps in the walls. All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Experimental: Partial House Screening - Traditional House
Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in traditional homes.
Partial screening will include either screening of the eaves or installing a screened ceiling, where no ceiling is present. In traditional houses, a netting (either insecticide-impregnated or untreated) may be either fixed in multiple places in the rafters or by hanging from a single central point and attached to the walls. No other screening or filling of the gaps will be done in partially screened houses.All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
Experimental: Partial House Screening - Modern House
Installation of partial screening, includee either screening of the eaves or installing a screened ceiling, in modern homes.
Partial screening will include either screening of the eaves or installing a screened ceiling, where no ceiling is present. In traditional houses, a netting (either insecticide-impregnated or untreated) may be either fixed in multiple places in the rafters or by hanging from a single central point and attached to the walls. No other screening or filling of the gaps will be done in partially screened houses.All households will be provided with piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs) - one for every two residents.
No Intervention: Control - Traditional House
Control group with no intervention in traditional homes
No Intervention: Control - Modern House
Control group with no intervention in modern homes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of malaria
Time Frame: 12 months following housing modification
Number of incident episodes of clinical malaria per time of observation. Incident episodes of malaria defined as any treatment for malaria > 14 days after any prior treatment for malaria
12 months following housing modification

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parasite prevalence
Time Frame: 12 months following housing modification
Proportion of study participants with a thick blood smear positive for asexual parasites as measured by microscopy
12 months following housing modification
Prevalence of anaemia
Time Frame: 12 months following housing modification
Proportion of haemoglobin measurements categorised as anaemia as per WHO age-stratified guidelines
12 months following housing modification
Vector density
Time Frame: 12 months following housing modification
Number of female Anopheles mosquitoes captured/room per night by CDC light traps
12 months following housing modification
Sporozoite rate
Time Frame: 12 months following housing modification
Proportion of captured female Anopheles mosquitoes that test positive for sporozoites
12 months following housing modification
Annual entomological inoculation rate
Time Frame: 12 months following housing modification
Number of infected bites per person per year (human biting rate x sporozoite rate x 365 days/year)
12 months following housing modification
Proportion of mosquitoes with insecticide resistance
Time Frame: 12 months following housing modification
Proportion of mosquitoes with phenotypic expression of insecticide resistance or containing genetic polymorphisms associated with resistance to insecticides of interest as identified by PCR
12 months following housing modification
Proportion of individuals satisfied with the interventions
Time Frame: 12 months following housing modification
Indicator of acceptability
12 months following housing modification
Proportion of households that require minimal maintenance of the implemented intervention over the period of the study, by study intervention
Time Frame: 12 months following housing modification
Indicator of durability
12 months following housing modification
Longer term cost of the maintenance and upkeep of the implemented intervention, by study intervention
Time Frame: 12 months following housing modification
Indicator of durability
12 months following housing modification
Costs of housing improvements, including maintenance, by improvement type
Time Frame: 12 months following housing modification
Indicator of feasibility
12 months following housing modification
Incremental cost-effectiveness ratios (ICER) of each package
Time Frame: 12 months following housing modification
Cost per malaria case averted, Cost per DALY averted
12 months following housing modification
Proportion of households that received the assigned housing modification
Time Frame: 12 months following housing modification
Indicator of fidelity
12 months following housing modification
Proportion of households that received 1 PBO LLIN for every 2 residents
Time Frame: 12 months following housing modification
Indicator of fidelity
12 months following housing modification
Proportion of households that received full/partial/no housing modifications
Time Frame: 12 months following housing modification
Dose delivered
12 months following housing modification
Proportion of households that received adequate/inadequate/no PBO LLINs
Time Frame: 12 months following housing modification
Dose delivered
12 months following housing modification
Proportion of households that utilized full/partial/no housing modifications
Time Frame: 12 months following housing modification
Dose received
12 months following housing modification
Proportion of household residents that slept under a PBO LLIN the previous night
Time Frame: 12 months following housing modification
Dose received
12 months following housing modification
Proportion of households that were fully covered by the assigned housing modification
Time Frame: 12 months following housing modification
Indicator of reach
12 months following housing modification
Proportion of household residents that were fully covered by the PBO LLINs
Time Frame: 12 months following housing modification

Indicator of reach

Proportion of households fully covered by both the modifications & PBO LLINs

12 months following housing modification
Proportion of households fully covered by both the modifications & PBO LLINs
Time Frame: 12 months following housing modification
Indicator of reach
12 months following housing modification

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nelli Westercamp, PhD MBA, Centers for Disease Control and Prevention
  • Principal Investigator: Moses Kamya, MBChB PhD, Infectious Diseases Research Collaboration

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2021

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

November 4, 2020

First Submitted That Met QC Criteria

November 4, 2020

First Posted (Actual)

November 9, 2020

Study Record Updates

Last Update Posted (Actual)

August 4, 2022

Last Update Submitted That Met QC Criteria

August 2, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 72061720FA00002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia

Clinical Trials on Eave Tubes

Subscribe